1 April 2024 false No description of principal activity Taxfiler 2024.6 4567617 business:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 4567617 2024-03-31 4567617 2024-04-01 2025-03-31 4567617 business:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 4567617 business:FilletedAccounts 2024-04-01 2025-03-31 4567617 2025-03-31 4567617 business:Director1 2024-04-01 2025-03-31 4567617 business:RegisteredOffice 2024-04-01 2025-03-31 4567617 2024-03-31 4567617 core:WithinOneYear 2025-03-31 4567617 core:WithinOneYear 2024-03-31 4567617 core:ShareCapital core:PreviouslyStatedAmount 2025-03-31 4567617 core:ShareCapital core:PreviouslyStatedAmount 2024-03-31 4567617 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-03-31 4567617 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-03-31 4567617 core:PreviouslyStatedAmount 2025-03-31 4567617 core:PreviouslyStatedAmount 2024-03-31 4567617 business:SmallEntities 2024-04-01 2025-03-31 4567617 countries:EnglandWales 2024-04-01 2025-03-31 4567617 core:LandBuildings 2024-04-01 2025-03-31 4567617 core:FurnitureFittings 2024-04-01 2025-03-31 4567617 core:LandBuildings 2024-03-31 4567617 core:LandBuildings 2025-03-31 4567617 core:AdditionsToInvestments 2025-03-31 4567617 core:AfterOneYear 2025-03-31 4567617 core:AfterOneYear 2024-03-31 4567617 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 4567617 (England and Wales)
Cochrane Opportunity Enterprises Limited Unaudited accounts for the year ended 31 March 2025
Cochrane Opportunity Enterprises Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Cochrane Opportunity Enterprises Limited Company Information for the year ended 31 March 2025
Director
Lyndsay Cochrane
Company Number
4567617 (England and Wales)
Registered Office
5 Commercial Street Ystradgynlais Swansea SA9 1HD United Kingdom
Accountants
RGS Accountants Limited 5 Commercial Street Ystradgynlais Swansea SA9 1HD
- 3 -
Cochrane Opportunity Enterprises Limited Statement of financial position as at 31 March 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
351,900
351,900
Investments
5
868,688
730,000
1,220,588
1,081,900
Current assets
Debtors
6
271,770
349,664
Cash at bank and in hand
135,393
121,368
407,163
471,032
Creditors: amounts falling due within one year
7
(22,367)
(5,930)
Net current assets
384,796
465,102
Net assets
1,605,384
1,547,002
Capital and reserves
Called up share capital
2
2
Profit and loss account
1,605,382
1,547,000
Shareholders' funds
1,605,384
1,547,002
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 21 September 2025 and were signed on its behalf by
Lyndsay Cochrane Director Company Registration No. 4567617
- 4 -
Cochrane Opportunity Enterprises Limited Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Cochrane Opportunity Enterprises Limited is a private company, limited by shares, registered in England and Wales, registration number 4567617. The registered office is 5 Commercial Street, Ystradgynlais, Swansea, SA9 1HD, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
NIL
Fixtures & fittings
Reducing balance: 25% per annum
4
Tangible fixed assets
Land & buildings
£
Cost or valuation
At cost
At 1 April 2024
351,900
At 31 March 2025
351,900
Depreciation
At 31 March 2025
-
Net book value
At 31 March 2025
351,900
At 31 March 2024
351,900
5
Investments
Other investments
£
Valuation at 1 April 2024
730,000
Additions
138,688
Valuation at 31 March 2025
868,688
- 5 -
Cochrane Opportunity Enterprises Limited Notes to the Accounts for the year ended 31 March 2025
6
Debtors
2025
2024
£
£
Amounts falling due within one year
Other debtors
65,394
103,152
Amounts falling due after more than one year
Other debtors
206,376
246,512
7
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
19,967
3,530
Other creditors
2,400
2,400
22,367
5,930
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -